thiazoles has been researched along with Juvenile Chronic Myelogenous Leukemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barber, DL; Huang, K; Javadi, M; Richmond, TD | 1 |
| Bunda, S; Favre, H; Irwin, MS; Kang, MW; Loh, ML; Ohh, M; Shin, DH; Sybingco, SS; Weng, J | 1 |
2 other study(ies) available for thiazoles and Juvenile Chronic Myelogenous Leukemia
| Article | Year |
|---|---|
CBL linker region and RING finger mutations lead to enhanced granulocyte-macrophage colony-stimulating factor (GM-CSF) signaling via elevated levels of JAK2 and LYN.
Topics: Amino Acid Substitution; Cell Line; Cytokine Receptor Common beta Subunit; Dasatinib; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Leukemic; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Janus Kinase 2; Leukemia, Myelomonocytic, Juvenile; Mutation, Missense; Phosphorylation; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-cbl; Pyrimidines; Pyrrolidines; RING Finger Domains; Signal Transduction; src-Family Kinases; Sulfonamides; Thiazoles | 2013 |
Inhibition of SRC corrects GM-CSF hypersensitivity that underlies juvenile myelomonocytic leukemia.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cytokine Receptor Common beta Subunit; Dasatinib; Drug Resistance, Neoplasm; Granulocyte-Macrophage Colony-Stimulating Factor; HEK293 Cells; Humans; Leukemia, Myelomonocytic, Juvenile; Phosphorylation; Protein Binding; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-cbl; Pyrimidines; src-Family Kinases; Thiazoles; Ubiquitination | 2013 |